| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |